166 related articles for article (PubMed ID: 35237181)
1. Circulating Fatty Objects and Their Preferential Presence in Pancreatic Cancer Patient Blood Samples.
Wang R; Nissen NN; Zhang Y; Shao C; Chu CY; Huynh C; Posadas EM; Tomlinson JS; Lewis MS; Pandol SJ
Front Physiol; 2022; 13():827531. PubMed ID: 35237181
[TBL] [Abstract][Full Text] [Related]
2. Subtype-Specific Selection for Resistance to Fluoroquinolones but Not to Tetracyclines Is Evident in Campylobacter jejuni Isolates from Beef Cattle in Confined Feeding Operations in Southern Alberta, Canada.
Webb AL; Selinger LB; Taboada EN; Inglis GD
Appl Environ Microbiol; 2018 Apr; 84(7):. PubMed ID: 29352087
[No Abstract] [Full Text] [Related]
3. [Detection of circulating tumor cells from peripheral blood in patients with transitional cell carcinoma--pilot study. Comparison with the standard histopathological staging].
Nagy V; Rosocha J; Zidzik J; Bohus P
Klin Onkol; 2011; 24(4):287-92. PubMed ID: 21905620
[TBL] [Abstract][Full Text] [Related]
4. Detection of pancreatic and gastric cancer cells in peripheral and portal blood by amplification of keratin 19 mRNA with reverse transcriptase-polymerase chain reaction.
Aihara T; Noguchi S; Ishikawa O; Furukawa H; Hiratsuka M; Ohigashi H; Nakamori S; Monden M; Imaoka S
Int J Cancer; 1997 Jul; 72(3):408-11. PubMed ID: 9247282
[TBL] [Abstract][Full Text] [Related]
5. Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial.
Barco S; Bingisser R; Colucci G; Frenk A; Gerber B; Held U; Mach F; Mazzolai L; Righini M; Rosemann T; Sebastian T; Spescha R; Stortecky S; Windecker S; Kucher N
Trials; 2020 Sep; 21(1):770. PubMed ID: 32907635
[TBL] [Abstract][Full Text] [Related]
6. TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer.
Reig Ò; Marín-Aguilera M; Carrera G; Jiménez N; Paré L; García-Recio S; Gaba L; Pereira MV; Fernández P; Prat A; Mellado B
Eur Urol; 2016 Nov; 70(5):709-713. PubMed ID: 26948395
[TBL] [Abstract][Full Text] [Related]
7. A Circulating Tumor Cell-RNA Assay for Assessment of Androgen Receptor Signaling Inhibitor Sensitivity in Metastatic Castration-Resistant Prostate Cancer.
Jan YJ; Yoon J; Chen JF; Teng PC; Yao N; Cheng S; Lozano A; Chu GCY; Chung H; Lu YT; Chen PJ; Wang JJ; Lee YT; Kim M; Zhu Y; Knudsen BS; Feng FY; Garraway IP; Gao AC; Chung LWK; Freeman MR; You S; Tseng HR; Posadas EM
Theranostics; 2019; 9(10):2812-2826. PubMed ID: 31244925
[No Abstract] [Full Text] [Related]
8. AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide.
Seitz AK; Thoene S; Bietenbeck A; Nawroth R; Tauber R; Thalgott M; Schmid S; Secci R; Retz M; Gschwend JE; Ruland J; Winter C; Heck MM
Eur Urol; 2017 Nov; 72(5):828-834. PubMed ID: 28818355
[TBL] [Abstract][Full Text] [Related]
9. Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA).
Mehra N; Dolling D; Sumanasuriya S; Christova R; Pope L; Carreira S; Seed G; Yuan W; Goodall J; Hall E; Flohr P; Boysen G; Bianchini D; Sartor O; Eisenberger MA; Fizazi K; Oudard S; Chadjaa M; Macé S; de Bono JS
Eur Urol; 2018 Sep; 74(3):283-291. PubMed ID: 29500065
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation.
Arnoletti JP; Reza J; Rosales A; Monreal A; Fanaian N; Whisner S; Srivastava M; Rivera-Otero J; Yu G; Phanstiel Iv O; Altomare DA; Tran Q; Litherland SA
PLoS One; 2022; 17(3):e0265725. PubMed ID: 35316296
[TBL] [Abstract][Full Text] [Related]
11. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
12. Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients.
Obermayr E; Sanchez-Cabo F; Tea MK; Singer CF; Krainer M; Fischer MB; Sehouli J; Reinthaller A; Horvat R; Heinze G; Tong D; Zeillinger R
BMC Cancer; 2010 Dec; 10():666. PubMed ID: 21129172
[TBL] [Abstract][Full Text] [Related]
13. Nuclear-specific AR-V7 Protein Localization is Necessary to Guide Treatment Selection in Metastatic Castration-resistant Prostate Cancer.
Scher HI; Graf RP; Schreiber NA; McLaughlin B; Lu D; Louw J; Danila DC; Dugan L; Johnson A; Heller G; Fleisher M; Dittamore R
Eur Urol; 2017 Jun; 71(6):874-882. PubMed ID: 27979426
[TBL] [Abstract][Full Text] [Related]
14. All circulating EpCAM+CK+CD45- objects predict overall survival in castration-resistant prostate cancer.
Coumans FAW; Doggen CJM; Attard G; de Bono JS; Terstappen LWMM
Ann Oncol; 2010 Sep; 21(9):1851-1857. PubMed ID: 20147742
[TBL] [Abstract][Full Text] [Related]
15. Exploring effective implementation pathways to become an excellent chief financial officer in public hospital: a qualitative comparative analysis (QCA) from China.
Wang H; Li J; Xiang X
BMC Health Serv Res; 2024 Jan; 24(1):124. PubMed ID: 38263000
[TBL] [Abstract][Full Text] [Related]
16. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
18. The emerging role of circulating tumor cell detection in genitourinary cancer.
Small AC; Gong Y; Oh WK; Hall SJ; van Rijn CJ; Galsky MD
J Urol; 2012 Jul; 188(1):21-6. PubMed ID: 22578722
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating cancer cells in peripheral blood detected by reverse transcriptase-polymerase chain reaction in patients with breast cancer.
An XY; Egami H; Hayashi N; Kurusu Y; Yamashita JI; Ogawa M
Tohoku J Exp Med; 2001 Feb; 193(2):153-62. PubMed ID: 11318030
[TBL] [Abstract][Full Text] [Related]
20. Nanotheranostics of circulating tumor cells, infections and other pathological features in vivo.
Kim JW; Galanzha EI; Zaharoff DA; Griffin RJ; Zharov VP
Mol Pharm; 2013 Mar; 10(3):813-30. PubMed ID: 23379366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]